financetom
Business
financetom
/
Business
/
Serina Therapeutics Raises $5 Million for Clinical Development of Parkinson's Drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Serina Therapeutics Raises $5 Million for Clinical Development of Parkinson's Drug
Apr 8, 2025 2:15 PM

04:45 PM EDT, 04/08/2025 (MT Newswires) -- Serina Therapeutics ( SER ) said Tuesday that it raised $5 million in financing from shareholders, which will be utilized to support the development of POZ-apomorphine to treat Advanced Parkinson's disease.

The phase 1 clinical trial of the candidate is expected to commence in Q4, the company said.

The company raised the financing by issuing 965,250 shares of convertible preferred stock at $5.18 per share.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved